Abstract:Background Aging-related inflammation is associated with chronic diseases and mortality. This study aimed to: 1) develop composite inflammaging metrics (CIMs) in UK biobank (UKB), and validate them in UKB and National Health and Nutrition Examination Survey (NHANES); 2) estimate mortality and CVD risk predictions of CIMs; 3) compare CIMs with single inflammatory blood biomarkers and conventional inflammatory indexes; 4) examine associations between lifestyles and CIMs. Methods We utilized algorithms including multiple linear regression, principal component analysis (PCA), allostatic load (AL), and Klemera and Doubal method (KDM), to develop four CIMs from five inflammatory blood biomarkers, using data of 438,321 adults (40-70 years) from UK Biobank (UKB). We validated these CIMs in UKB and 10,667 adults (20-84 years) from NHANES IV. We performed a parametric proportional hazard model based on Gompertz distribution to estimate CVD and mortality risk predictions of CIMs. Areas under receiver operating characteristic curves (AUCs) were calculated to compare the predictive abilities of CIMs. Multiple linear regression models were used to access associations between lifestyles and CIMs. Results With adjustment for age and sex, four CIMs were significantly associated with higher risks of all-cause mortality and incident CVD in UKB, among which CIMKDM outperformed the others (all-cause mortality: hazard ratio [HR] = 1.48, 95% confidence interval [CI] = 1.46, 1.50; incident CVD: HR = 1.34, 95% CI = 1.33, 1.36). CIMKDM had the best discriminative ability for predicting 10-year survival and incident CVD in UKB (all-cause mortality: AUC = 0.728; incident CVD: AUC = 0.712). CIMs were responsive to lifestyle variables. For example, in UKB, compared to never smokers, current smokers had a significant increment in CIMKDM (coefficient = 0.30 SD, P < 0.001). Similar results were well validated in NHANES IV. Conclusions We developed and validated four novel CIMs that were predictive of mortality and CVD risk. CIMKDM outperformed the others and had the potential to be used in aging related preventive and intervention programs. Intervention programs targeting lifestyles could slow inflammaging and further reduce disease burden. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LQ21H260003), the National Natural Science Foundation of China (82171584), the 2020 Milstein Medical Asian American Partnership Foundation Irma and Paul Milstein Program for Senior Health project award (ZL), fundings from Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province (2020E10004), and Zhejiang University Global Partnership Fund (188170-11103). The funders had no role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: UKB data was approved by the North West Multi-centre Research Ethics Committee (ref. 11/NW/0382). All participants provided written informed consent. NHANES data were openly available to the public before the initiation of the study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes NHANES data produced are available online at (https://www.cdc.gov/nchs/nhanes/index.htm). UKB data has been conducted using the UKB resource under application number 61856.

Biolearn, an open-source library for biomarkers of aging

Development and Validation of Two Composite Aging Measures Using Clinical Biomarkers in the Chinese Population

An Open Competition for Biomarkers of Aging

Validation of biomarkers of aging

A toolkit for quantification of biological age from blood chemistry and organ function test data: BioAge

Development and validation of composite inflammaging metrics: Findings from two prospective cohort studies

Development and Validation of 2 Composite Aging Measures Using Routine Clinical Biomarkers in the Chinese Population: Analyses from 2 Prospective Cohort Studies.

AgingBank: a manually curated knowledgebase and high-throughput analysis platform that provides experimentally supported multi-omics data relevant to aging in multiple species

Molecular and phenotypic biomarkers of aging [version 1; referees: 3 approved]

Challenges and recommendations for the translation of biomarkers of aging

A Machine Learning Based Aging Measure among Middle-Aged and Older Chinese Adults: the China Health and Retirement Longitudinal Study

Large‐Scale metabolomics: Predicting biological age using 10,133 routine untargeted LC–MS measurements

Molecular and phenotypic biomarkers of aging

Biohorology and biomarkers of aging: Current state-of-the-art, challenges and opportunities

Deep biomarkers of human aging: Application of deep neural networks to biomarker development.

pyaging : a Python-based compendium of GPU-optimized aging clocks

Biomarkers of aging in real life: three questions on aging and the comprehensive geriatric assessment

Serum Metabolomic Profiling in Aging Mice Using Liquid Chromatography—Mass Spectrometry

Gompertz law based biological age (GOLD BioAge): a simple and practical measurement of biological aging to capture morbidity and mortality risks

Progress in the study of aging marker criteria in human populations

Epigenomic, Transcriptome And Image-Based Biomarkers Of Aging